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Radio- and nano-chemistry of aqueous Ga(III) ions
anchored onto graphene oxide-modified
complexes†
S. Sarpaki,‡a F. Cortezon-Tamarit, ‡a S. R. M. M. de Aguiar,‡a R. M. Exner, a
D. Divall,a R. L. Arrowsmith,a H. Ge,a F. J. Palomares, b L. Carroll, c
D. G. Calatayud, d S. J. Paisey,e E. O. Aboagyef and S. I. Pascu *a
The gallium-68 radiolabelling of new functional graphene oxide
composites is reported herein along with kinetic stability investi-
gations of the radio-nanohybrids under different environments
and insights into their surface characteristics by SEM and XPS. The
present work highlights the potential of graphene oxides as nano-
carriers for small molecules such as bis(thiosemicarbazonato)
complexes to act as multifunctional platforms for rapid and
effective radioimaging agent incorporation.
The research field of nanotechnology has been continuously
advancing over the past 20 years on account of the unique
physicochemical properties of emergent nanostructured
materials including graphene and functional graphenes. This
has allowed for innovative applications in broad areas of bio-
medical sciences and already provides potential solutions to
many of the current scientific and technological challenges
such as those of new developments in biosensing as well as in
nanomedicine design and testing. In this context, graphene
and graphene oxide have shown great potential in the develop-
ment of a broad range of biomedical applications.1,2 Due to
graphene oxide’s improved water solubility and superior bio-
compatibility in comparison to graphene or other nano-
particles (e.g. metallic nanoparticles), its use as a nanocarrier
for drug/gene delivery3–7 or as a probe in molecular imaging is
being explored.6–11 Currently, functional graphenes and their
covalent and non-covalent functionalised derivatives have
been investigated as potential nanoplatforms for a variety of
imaging techniques, such as magnetic resonance imaging
(MRI),8,12–14 fluorescence,8,15–17 positron emission tomography
(PET) and photoacoustic imaging.8,18–20 In addition, the com-
bination of different imaging modalities on the same nano-
composite has been explored.8,21,22
Several recent studies show that graphene oxide (GO) nano-
composites can be conjugated with polyethylene glycol (PEG)
or small chelating molecules (e.g. 1,4,7-triazacyclononane-
1,4,7-trisacetic acid, deferoxamine, etc.) and, in turn, radio-
labelled with various radioisotopes (e.g. iodine-131, gallium-
66, gallium-68, copper-64).8,23–25 for their use in nuclear
imaging.
Recently Cai et al. suggested that the chelator-free labelling
of GO nanocomposites with copper-64 is possible, allowing for
the facile synthesis of new radio-nanocomposites with high
kinetic stability.26,27 These radiolabelling processes can be
carried out under mild conditions and rely on the interaction
between the transition metal and π electrons and oxygen func-
tionalities present on GO surface. Although this approach
offers an attractive alternative for the radiolabelling of GO,
only a few examples have been reported using copper-64 or
fluorine-18.26–28
Despite the progress achieved so far, there are still many
synthetic limitations to be resolved in order to develop new
materials that are not only biocompatible but also stable,
allowing for the development of new versatile contrast agents.
In this sense, the large surface area of sp2-bound carbon in
graphene oxide nanocomposites added to the presence of
oxygen functionalities become a crucial factor for the functio-
nalisation of graphene covalently, or non-covalently via π–π
interactions, hydrogen bonding or van der Waals forces.
In this work, we demonstrated the feasibility of graphene
oxide as a potential chelator-free imaging contrast in [68Ga]Ga
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(III)-radiolabelling with excellent radiochemical yields. The pre-
pared graphene oxide nanocomposites also incorporated func-
tional bis(thiosemicarbazonato) metal complexes and tested
the applicability of these derivatives in vitro paving the way
towards the potential application in PET imaging of graphene
oxide-based multimodality imaging nanoprobes.
The unsymmetrical bis(thiosemicarbazonato) zinc complex
(2), synthesised as described in Fig. 1 and ESI,† was selected
for the potential enhancement of the GO-based radio-
nanocomposite properties as related/similar compounds have
shown inherent hypoxia selectivity.29,30 In this case, a free
amino group incorporated in the ligand framework at the exo-
cyclic N(H) in 2 opens the way for future straightforward bio-
conjugations. The synthesis of gallium bis(thiosemicarbazo-
nato) complex was additionally carried out: the non-radio-
labelled and radiolabelled gallium(III) complexes (3 and [68Ga]-
3) were prepared via an optimised, transmetallation protocol
from the corresponding zinc complex precursor (2) allowing
for a reduction in reaction times and increased reaction yields
(Tables S3 and S4, ESI†). The radiochemical purity of the
gallium-68 complex was demonstrated by HPLC and radio-
HPLC: Fig. 2(A) shows a comparison of the relevant traces of
Compound 3 and the corresponding species [68Ga]-3.
The aqueous gallium(III) and [68Ga]gallium(III) ions were
subsequently incorporated into two different nanoparticulate
systems: a simple GO framework and a GO-based hybrid incor-
porating a molecular bis(thiosemicarbazonato) zinc complex
(2@GO), as described in Fig. 1(B). The gallium-tagged nano-
composites were successfully prepared by mixing a GO suspen-
sion in DMSO (2 mg mL−1) with GaCl3 in a 4 : 1 ethanol :
sodium acetate buffer solution (pH = 4.5) at 95 °C for
45 minutes. Next the [68Ga]Ga(III) radiolabelling was achieved
following the analogous procedure employed for the non-
radioactive counterparts. This resulted in the isolation of the
two radioactive hybrids, or nanocomposites, denoted [68Ga]
Ga@GO and [68Ga]Ga-2@GO. The source of the [68Ga]GaCl3
(aq.) i.e. whether it was generator vs. cyclotron produced did
not appear to play a crucial role in the formation of a nanohy-
brid: the labelling was successful with gallium-68 produced by
a cyclotron via the 89Zn(p,n)68Ga reaction in aqueous solution,
or eluted through a [68Ge]/[68Ga] generator, in both cases the
impurities present after extractions appeared to play a negli-
gible role in the immobilisation of radioactive species within
the support. All the reactions were monitored using radioactive
instant thin layer chromatography (radio-iTLC). The radio-
iTLC, based on the percentage of activity detected on the base-
line by paper chromatography (Whatman 3MM), suggested
that after 45 min the radiochemical conversion (RCCs) for
both [68Ga]-labelled GO nanocomposites was higher than 99%
as single radioactive species were detected for each Radio-iTLC
run (Fig. 2B and Fig. S65 of ESI†). The radiochemical yield of
crude gallium-68 nanocomposites was calculated to be notably
high and varied between the different nanocomposites used
from 98 ± 4.6% to 99.7 ± 0.74%. It can be assumed that label-
ling was enabled by interactions of the oxophilic Ga(III) ion
Fig. 1 (A) Synthetic procedure for complexes 2 and 3. (i) EtOH, HCl,
reflux, 2 h; (ii) EtOH, HCl, μW 90 °C, 10 min; (iii) Zn(OAc)2, (NH2NH)2CS,
CH3COOH, 120 °C, 28 h; (iv) Zn(OAc)2, (NH2NH)2CS, EtOH, HCl, μW
150 °C, 1 h 46 min; (v) GaCl3, MeOH, reflux, 6 h; (vi) [
68Ga]GaCl3, MeOH,
NaOAc, 95 °C, 45 min. (B) Formation of nano-composites denoted
Ga@GO, Ga-2@GO and of radiolabelled analogues. (vii) Complex 2,
NaHCO3, reflux, 2.5 h; (viii) GaCl3, NaHCO3, 100 °C, 2.5 h; (ix) [
68Ga]
GaCl3, NaHCO3, 95 °C, 45 min.
Fig. 2 (A) HPLC and radio-HPLC traces for complexes 3 (blue), and
[68Ga]-3 (red). (B) Radiochemical data for the [68Ga]-radiolabelling of
GO nanocomposites. Small impurities at 11 min are assignable to proto-
nation and/or Ga–Cl/Ga–OH exchanges in water. Radio-iTLC of [68Ga]
Ga@GO and [68Ga]Ga-2@GO (C18 paper TLC, mobile phase: 0.35 M
EDTA).
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with the surface functionalities of GO, although transition
metal-π electron interactions based on the electron transfer
between Ga(III) cations, well-known hard/intermediate Lewis
acids and π electron density on the surface of GO, may further
facilitate this binding.
The kinetic stability of both non-radiolabelled (Ga@GO and
Ga-2@GO) and radiolabelled nanocomposites ([68Ga]Ga@GO
and [68Ga]Ga-2@GO) was evaluated under various conditions.
For the kinetic stability tests of the non-radiolabelled com-
plexes, (Ga@GO and Ga-2@GO) UV-visible absorption spec-
troscopy was employed. Specifically, 2 mg mL−1 concentration
of the assay agent (complex Ga@GO or Ga-2@GO) dispersed
in DMSO was used. Dispersions of assay agents in 1 : 1
DMSO : H2O mixtures were prepared, and the assays were
carried out by incubating the samples at 37 °C using citric
acid, PBS, EDTA and DFO. Both complexes were found to be
sufficiently stable in the timescale of an imaging experiment
with respect to decomposition in a mixture of DMSO and
several aqueous buffers, which are of relevance to standard cel-
lular imaging assays. Whilst there were no changes observed
in the UV/Vis spectra after 30 minutes of incubation, some
slight changes were observed after 24 hours of incubation
(Fig. S52 in ESI†). Moreover, on account of the short half-life
(t1/2) of [
68Ga]Ga(III) (68 minutes), the kinetic stability of the
radiolabelled compounds was tested after incubation at 37 °C
for 60 and 120 minutes. It was found that the stability profile
of the radiolabelled complex was high with >98% of the radio-
labelled GO nanocomposites remaining intact during incu-
bation in biological media (e.g. PBS, mouse plasma) at a
volume ratio of 1 : 1 of the radiolabelled GO nanocomposites
to biological media. On the other hand, the stability in EDTA
decreased compared to biological media with only >65%
remaining intact after one hour, which might be caused by the
strong ability of EDTA to bind gallium(III).31 Fig. 3 shows a bar
graph representation summarising the stability assay results
for the [68Ga]Ga@GO and [68Ga]Ga-2@GO nanocomposites.
Interestingly, the ananlogous methodology could be extrapol-
lated to the chelator-free [89Zr]Zr-labelling of GO [ESI†]. The
incorporation of (cyclotron-produced) aqueous 89Zr(IV) into the
2@GO hybrid was also attempted to test the hypothesis
that the Lewis acidity and oxophilicity of Zr(IV) would lead
to specific radiolabelling. Further investigations of the
potential radiolabelling using [89Zr]Zr(IV) (aqueous ions, fre-
quently highlighted as a mixture of colloidal oxo-zirconium
ions) in the presence of the well-known zirconium chelator,
the siderophore-like deferoxamine (DFO) derivative, were
carried out hereby. The radiolabelled [89Zr]ZrDFO was
treated in turn with the GO and 2@GO nanocomposites
and a 70% radio-incorporation of this complex was
observed. We hypothesise that this could be caused by
non-covalent binding between GO nanocomposites and
DFO. Our experiments did not indicate a strong kinetic
stability of the resulting 89Zr(IV)-tagged radio-nanohybrids
and did not confirm the strong binding of the zirconium-
89 to GO in the absence of the established chelator defer-
oxamine (DFO) (ESI, Fig. S40†).
To aid our understanding into the interaction within the
GO nanocomposites and gallium species on the nanoscale,
further analysis through TEM, SEM and EDX in the ‘cold’ Ga
(III) chemistry was applied. The electron microscopy images of
the corresponding ‘cold’ compounds indicated some level of
aggregation of the Ga+3 ions and of the Ga-2 complex on the
surface or between the layers of the GO flakes, suggesting an
interaction in solution (ESI†). The EDX mapping of Ga-2@GO
showed a high binding affinity of Ga(III) on the GO surface,
supporting the hypothesis that when bis(thiosemicarbazonato)
Zn(II) complex is incorporated non-covalently within the GO
layers, the normally straight-forward transmetallation Zn(II)/Ga
(III) reaction30 seems less favourable (Fig. 5). In order to
confirm the bonding condition of gallium and surface functio-
nalizations of graphene oxide XPS measurements were per-
formed. In survey scans, the expected emissions from core
level peaks can be observed (C 1s, N 1s, Zn 2p, Cl 2p, O 1s and
Ga 3p and 3d. These were present in samples Ga (3) and Ga-
2@GO, and C 1s, Cl 1s, O 1s and Ga 3p and 3d for Ga@GO.
For chemical analysis and comparison purposes, N 1s, Zn 2p
and Ga 3d levels were selected (Fig. 6). Interestingly, Fig. 6(a)
depicts the XPS emission attesting the presence of traces of
Zn: from the Zn 2p core level, whose binding energy and core
level splitting values confirm the presence of Zn2+ in both Ga
(3) and Ga-2@GO samples. The existence of Zn in the sample
Ga (3) can be ascribed to the transmetallation reaction, and
therefore the presence of small amounts of the Zn thiosemi-
carbazonato precursor, which are undetectable through
analytical techniques such as HPLC, NMR or mass spec-
trometry. Fig. 6(b) shows the XPS spectra corresponding to the
N 1s core level: for the samples Ga (3) and Ga-2@GO a peak at
ca. 399 eV can be observed corresponding to the
emission from N of the thiosemicarbazonato complexes; corre-
spondingly no N-related signal was detected for the Ga@GO
sample due to the absence of the thiosemicarbazato com-
plexes. In addition, for all samples a Cl 2p peak (Fig. S50,
ESI†) corresponding to the Cl–Ga bond was readily seen.
The sample Ga@GO shows, as expected, the highest Cl percen-
tage, due to the use of GaCl3 as the Ga(III) source. The obtained
Fig. 3 Kinetic stability tests: [68Ga]Ga@GO (left) and [68Ga]Ga-2@GO
(right) Nanocomposites were exposed up to 2 h to challenges under
various incubation conditions described in ESI.† Error bar stands for
standard error (±SE), calculated from three independent, repeated,
measurements.
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data confirms the presence of Ga(III) ions in all samples
(Fig. 6c). Both the binding energy position of the Ga 3d photo-
emission peak (ca. 21 eV) and the LMM Auger transitions
(Fig. S50 ESI†), shifted 3.0 eV and 6.0 eV with respect to the
values for metallic Ga, respectively, confirming the presence of
Ga3+ (ESI†). A detailed analysis of the Ga 3d energy region pro-
vides more information of its chemical state. At first, subtle
line shape asymmetry is observed on the low binding energy
side, which might be indicative of an additional emission
associated to a lower chemical state. Therefore, core level fit
has been performed considering components from O 2s, Ga
3d, Cl 3s, S 3s and Zn 3d signals present in that energy region.
The deconvolution results are displayed in Fig. 6(d), (e) and (f)
for all the samples. In addition to the main contribution
attributed to Ga3+, a minor component assignable to Ga–OH
exists (denoted Ga+1 in the Fig. 6), suggesting the possible
presence of Ga–OH-graphene oxide surface conjugations for
Ga@GO and Ga-2@GO and of Ga(OH)3 for Ga (3).
33–36 This is
an unprecedented account into the behaviour of gallium ions
in presence of graphene oxides and also shows an insight for
the first time into the Zn(II)/Ga(III) transmetallation from XPS
spectroscopy.
Furthermore, the cellular uptake of the complexes 2 and 3
and the corresponding nanocomposite 2@GO in living PC-3
cancer cells was investigated by laser confocal fluorescence
Fig. 5 Scanning Electron Microscopy (SEM): micrographs and corresponding EDX analysis of complexes and nanocomposites. (a) Complex 2; (b)
GO; (c) 2@GO; (d) Ga@GO and (e) Ga-2@GO. Scale bars: (a) 2 µm, (b) 1 µm, (c), (d) and (e) 5 µm. (f ) SEM image and corresponding EDX elemental
analysis and EDX mapping image (S, Cl, Zn, Ga) of Ga-2@GO nanocomposite.
Fig. 4 Single photon laser scanning confocal fluorescence imaging of
2 (a1–d1) in living HeLa cells (100 µM, 37 °C, 15 min incubation in
RPMI-0.5% DMSO) and 2@GO (a2–d2) in living PC-3 cells (10 µg mL
−1,
37 °C, 15 min incubation in RPMI-0.5% DMSO). (a1–2) Overlay of DIC,
blue, green and red channels; (b1–2) blue channel, λexc 405 nm, λem
420–480 nm; (c1–2) green channel, λexc 488 nm, λem 515–530 nm; (d1–2)
red channel, λexc 561 nm, λem 615–650 nm. Scale bar: 20 µm.
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microscopy (ESI†). Whilst these species display weak fluo-
rescence emission, consistent with all related studies on metal-
lated bis(thiosemicarbazonato) species, this was sufficient to
perform in vitro imaging (Fig. 4 and ESI†) by confocal fluo-
rescence microscopy. Complex 2 exhibited a stronger fluo-
rescence emission when localised within the cytoplasm of
living HeLa, PC-3 and MCF-7 cell lines, in line with previously
reported observations.29 Interestingly, complex 3 shows a
stronger fluorescence emission intensity under hypoxic con-
ditions (ESI†) consistent with previous findings on the hypoxia
selectivity of this family of gallium compounds supported on
rigid N/S ligand frameworks.29,30 Cellular cytotoxicity investi-
gations performed on the non-radiolabelled compounds in
PC-3 and EMT-6 cancer cell lines (ESI†) confirmed the low tox-
icity of the synthesised graphene oxide nanocomposites in
these particular cell lines, being suitable candidates as syn-
thetic scaffolds for anchoring imaging agents. Crystal violet
assays were carried out in the PC-3 and EMT-6 cancer cell
lines. All the GO composites investigated had low to minimum
toxicity under the selected experimental conditions11 and in
the case of the molecular compounds, their IC50 values are in
line with previous investigations into this family of bis(semi-
thiocarbazonato) complexes29 (Fig. S24–S29, ESI†). Functional
graphene oxides are now well known to be excreted in vivo
through the kidney and the gut:32 lack of cellular toxicity
reinforce the possibility of sustainable and safe radioactivity
entrapment by metal compounds anchored onto the 2D layers
of graphene oxides.
Conclusions
In conclusion, we report hereby the chelator-free radiolabelling
of GO nanocomposites with gallium-68. For the first time, GO
nanocomposites were directly radiolabelled with aqueous
[68Ga]GaCl3 through non-covalent interactions without the
need to use a chelator. Almost quantitative radioactivity incor-
poration was achieved in record times of under 1 h. The func-
tionalisation of the GO flakes with functional molecules was
demonstrated by using a Zn(II)-based bis(thiosemicarbazonato)
metal complex with enhanced fluorescence and provided
potential selectivity towards hypoxic tissues. The ease of func-
tionalisation may facilitate the application of GO nano-
composite as synthetic platforms towards biomedical/bio-
imaging applications. Our hypotheses for the nanohybrid for-
mation were verified by utilising different types of microscopy
(optical and SEM) and chemical analysis of the material and
resultant complexes at the local scale (nano) and micro-scale.
Furthermore, XPS measurements shed light onto the nature of
the emerging bonding interactions and confirmed our success-
ful developments in the rapid assembly of new radioactive
nanohybrids based on gallium ions, directly or as complex
ions incorporating the Ga/S/N cores. The kinetic stability of
the complexes proved to be excellent in PBS or serum in the
timescale of an imaging experiment. In addition, crystal violet
assays were carried out on the non-radiolabelled complexes
indicating high cell viability, rendering them appropriate can-
didates as imaging agents as well as of interest for radioactive
waste-water remediation and storage for longer lived isotopes.
These findings open up new vistas for radio-nanomaterials
research avenues and bring about a new focus on the future
use of affordable, water-dispersible and biocompatible 2D-
materials such as graphene oxides as radio-nanomedicine
building blocks.
Conflicts of interest
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Fig. 6 XPS spectra of core levels (a) Zn 2p, (b) N 1s, (c) Ga 3d. (d) Ga 3d energy region for the Ga@GO sample with a fit of a Ga3+, 3 Ga–O singlet,
Ga1+, and Ga–Cl, (e) and (f ) same scenario than (d) but for the Ga (3) and Ga-2@GO samples.
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